Cargando…
Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma
[Image: see text] Even in the era of personalized medicine and immunotherapy, temozolomide (TMZ), a small molecule DNA alkylating agent, remains the standard-of-care for glioblastoma (GBM). TMZ has an unusual mode-of-action, spontaneously converting to its active component via hydrolysis in vivo. Wh...
Autores principales: | Svec, Riley L., Furiassi, Lucia, Skibinski, Christine G., Fan, Timothy M., Riggins, Gregory J., Hergenrother, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243397/ https://www.ncbi.nlm.nih.gov/pubmed/30296373 http://dx.doi.org/10.1021/acschembio.8b00864 |
Ejemplares similares
-
The Medicinal Chemistry of Imidazotetrazine Prodrugs
por: Moody, Catherine L., et al.
Publicado: (2014) -
Antitumour imidazotetrazines: past, present… and future?
por: Stevens, Malcolm F. G., et al.
Publicado: (2023) -
Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.
por: Goddard, C., et al.
Publicado: (1985) -
A Phosphonate Natural Product Made by Pantoea ananatis is Necessary and Sufficient for the Hallmark Lesions of Onion Center Rot
por: Polidore, Alexander L. A., et al.
Publicado: (2021) -
C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage
por: Yang, Zhikuan, et al.
Publicado: (2019)